A CRISPR nickase shrank Huntington's repeats in mouse brains — and improved movement
Gene editing got a little more therapeutic this week — a CRISPR tool designed to nick, not cut, shrank the stuttering DNA repeats behind Huntington's disease in living mouse brains.
Elsewhere, a phage pulled off a molecular con job that has researchers rethinking how CRISPR defenses can be beaten.
🧠 A CRISPR Nickase Took a Bite Out of Huntington's — in Actual Neurons
- Researchers used a Cas9 nickase — a gentler version that cuts only one DNA strand — to shrink the expanded CAG repeats behind Huntington's disease. It worked in patient-derived neurons and astrocytes, and in a living mouse model.
- In the R6/1 mouse striatum, repeat contractions showed up in more than half of neurons after a single injection. The mice had fewer toxic protein clumps, a healthier gene expression profile, and measurably better movement in open-field tests.
- The approach was allele-selective — meaning it targeted the disease copy — and no detectable off-target mutations were found. The behavioral improvements were larger than the contraction rates alone would predict, suggesting neighboring cells may also be responding.
Why it matters: More than 15 diseases share this same repeat-expansion problem. A tool that contracts the repeats without cutting both strands — and without off-target edits — changes the calculus on what's fixable.
Key Findings
🦠 A Phage RNA Fools Cas9 by Wearing Its Own Guide as a Disguise
- Scientists identified a phage-encoded small RNA, rAcrIIA1, that mimics the full single-guide RNA Cas9 needs to function. It binds Cas9 nearly identically to the real guide, blocking the system from loading any actual guide RNA and shutting down DNA cutting.
- Structural analysis of the Cas9-rAcrIIA1 complex confirmed the mimicry. Crucially, the RNA is also reprogrammable: swap in a variable guide sequence and it directs Cas9 to cut specific DNA targets with efficiency comparable to the standard guide.
🧬 Human Argonaute 2 Repurposed as an RNA Editor — With Fewer Foreign-Protein Concerns
- Researchers fused human Argonaute 2 (AGO2) to a deaminase enzyme to create ALTER, a C-to-U RNA editor built entirely from human proteins. In HEK293T cells, ALTER achieved on average 1.9-fold higher editing efficiency on messenger RNA targets compared to Cas13-based editors.
- Because the scaffold is human, machine learning models predicted far fewer immunogenic peptides — a practical concern when moving toward therapeutic use. Off-target editing was similar to or lower than Cas13 comparators.
🔬 A Phage Repair Kit Patches CRISPR Cuts — and Doubles as a Genome-Editing Tool
- A two-protein system called Healer, encoded by phages, repairs DNA breaks caused by CRISPR rather than blocking the enzyme. One protein binds single-stranded DNA at the cut site; the other promotes homologous recombination to seal it.
- When co-expressed with Cas9 or Cas12 in three bacterial species — E. coli, P. aeruginosa, and A. baumannii — the Healer system showed high phage genome-editing efficiency, suggesting a dual role as both a phage survival tool and a genome-engineering scaffold.
🌽 Chromosome-Scale Plant Editing Is Moving From Single Genes to Whole Regions
- A review in Trends in Biotechnology maps how plant genome engineering has expanded from editing individual genes to rearranging megabase-scale chromosomal segments. Technologies now enable programmable deletions, insertions, inversions, and translocations across kilobase-to-megabase ranges.
- AI integration is accelerating optimization of these large-fragment tools, and the authors argue the field is transitioning from genome editing to chromosome engineering — with direct implications for crop breeding and plant synthetic biology.
🩸 Blocking a Mitochondrial Protein Sensitizes a Leukemia to Its Own Drug
- In acute myeloid leukemia driven by a common mutation called FLT3-ITD, cancer cells that resist the drug gilteritinib upregulate a mitochondrial protein called NDUFS2. A CRISPR screen pinpointed it; knocking it down impaired energy production and pushed resistant cells toward cell death.
- Combining a pharmacologic mitochondrial inhibitor with gilteritinib reduced leukemia burden in a patient-derived mouse model. A short-term safety assessment in mice showed no overt toxicity, though the authors frame this as preliminary.
🖐️ A Single Gene Controls Touch, Temperature, Pain, and Itch in Sensory Neurons
- Using a postnatal CRISPR-Cas9 screening platform delivered via AAV into mice, researchers knocked out 20 genes expressed in sensory neurons and tested behavior. One gene, Creld1, stood out: its loss caused profound deficits across touch, temperature, pain, and itch simultaneously.
- Mechanistically, CRELD1 appears to regulate voltage-gated sodium channels that control how easily sensory neurons fire. Overexpressing Creld1 had the opposite effect, enhancing touch and thermal responses.
Implications
The Huntington's nickase result and the Creld1 sensory discovery both point to the same emerging reality: CRISPR is moving from proof-of-concept edits to measurable phenotypic rescue. The unresolved tension is whether non-cell-autonomous effects — neighbors responding to edited cells — can be predicted or controlled well enough to treat humans safely.
Studies in this issue
Primary sources used for this newsletter.
- Reducing repeated DNA sections with Cas9 nickase is linked to symptom improvements in a Huntington’s disease mouse modelmain storyScience translational medicine2026-10-22PMID 42905851
- From Changing Genes to Reshaping Chromosomes in Plantskey findingTrends in biotechnology2026-10-20PMID 42901830
- Blocking a key mitochondrial protein boosts FLT3 inhibitor effects in acute myeloid leukemia with FLT3 mutationskey findingLeukemia2026-10-20PMID 42897233
- A phage DUF669 protein helps fix DNA after cutting to resist host CRISPR defensekey findingNature communications2026-10-22PMID 42907433
- A virus-made small RNA that mimics guide RNA to block CRISPR-Cas9key findingCell host & microbe2026-10-22PMID 42906550
- Designed human Argonaute 2 protein for precise RNA editing from C to Ukey findingNature biotechnology2026-10-20PMID 42902027
- Genes linked to behavior show Creld1 helps control different types of body sensationkey findingNature neuroscience2026-10-23PMID 42918863
Continue reading
All CRISPR Gene Editing issuesGet the next CRISPR Gene Editing issue
Seven papers, once a week. Free.